Please Wait.....
Report
Global Idiopathic Intracranial Hypertension Market Report and Forecast 2023-2031
Market Report I 2023-04-13 I 147 Pages I EMR Inc.
Global Idiopathic Intracranial Hypertension Market Report and Forecast 2023-2031
Global Idiopathic Intracranial Hypertension Market Outlook
The global idiopathic Intracranial hypertension market is expected to grow significantly during the forecast period of 2023-2031. The increasing prevalence of ADHD worldwide, coupled with the growing demand for effective treatments, is driving the growth of the market. The global ADHD treatment market is likely to grow at a CAGR of 4.27% during the forecast period.
Idiopathic Intracranial hypertension Market: Introduction
The global idiopathic intracranial hypertension (IIH) treatment market report by Expert Market Research provides an in-depth analysis of the market and its segments. IIH, also known as pseudotumor cerebri, is a neurological disorder characterized by increased intracranial pressure in the absence of any underlying pathology. The lack of effective treatments for IIH has been a major challenge for healthcare providers and researchers worldwide. The report covers the market for IIH treatment and provides a detailed analysis of the market size, growth, and trends.
The IIH treatment market is expected to witness significant advancements in the coming years. The development of novel therapies, such as surgical interventions and drug therapies, and the increasing focus on personalized medicine are likely to drive the growth of the market. Additionally, the expansion of healthcare infrastructure in emerging economies and the increasing demand for advanced diagnostic tools and treatment options are expected to create lucrative opportunities for the market players.
Moreover, the growing adoption of telemedicine and digital health technologies may provide new avenues for the management and treatment of IIH, potentially improving patient outcomes and reducing healthcare costs. As a result, the global IIH treatment market is expected to continue its growth trajectory throughout the forecast period, offering numerous opportunities for key players and investors in the industry.
Idiopathic Intracranial Hypertension Epidemiology
Idiopathic Intracranial Hypertension (IIH) is a rare neurological condition characterized by increased intracranial pressure in the absence of any underlying pathology. The exact prevalence of IIH is unknown, but it is estimated to affect 1-2 per 100,000 people in the general population. However, the incidence of IIH is increasing, particularly in obese women of childbearing age.
IIH is more common in women, with a female-to-male ratio of 9:1. The peak incidence of IIH occurs between the ages of 20 and 50, but the condition can affect individuals of any age, including children. The exact cause of IIH is unknown, but several risk factors have been identified, including obesity, female gender, and certain medications.
Idiopathic Intracranial Hypertension Market Segmentations
The market can be categorised into diagnosis method, and treatment channels.
Market Breakup by Diagnostic Method
- Carbonic Anhydrase Inhibitors
? Acetazolamide
? Methazolamide
? Others
- Loop Diuretics
? Furosemide
? Others
- Corticosteroids
- Anticonvulsant
? Topiramate
- Others
Market Breakup by Treatment Channels
- Public
- Private
Market Breakup by Region
- North America
? United States of America
? Canada
- Europe
? United Kingdom
? Germany
? France
? Italy
? Others
- Asia Pacific
? China
? Japan
? India
? ASEAN
? Australia
? Others
- Latin America
? Brazil
? Argentina
? Mexico
? Others
- Middle East and Africa
? Saudi Arabia
? United Arab Emirates
? Nigeria
? South Africa
? Others
Idiopathic Intracranial hypertension Market Scenario
The market for idiopathic intracranial hypertension (IIH) treatment is expected to grow significantly in the coming years, driven by the increasing prevalence of the condition and the growing demand for effective treatments. The lack of effective therapies for IIH has been a major challenge for healthcare providers and researchers worldwide, creating a significant unmet need in the market.
North America is the largest market for IIH treatment, followed by Europe and the Asia Pacific. The high prevalence of IIH in North America, coupled with the availability of advanced healthcare infrastructure, is driving the growth of the market in the region. Europe is also a significant market for IIH treatment, with the presence of key players and increasing investment in research and development activities. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period, owing to the increasing awareness about IIH and the rising healthcare expenditure in the region.
Key Players in the Global Idiopathic Intracranial Hypertension Market
The report gives an in-depth analysis of the key players involved in the idiopathic Intracranial hypertension market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
- Teva Pharmaceutical Industries Ltd
- Mylan N.V.
- Pfizer, Inc.
- Upsher-Smith Laboratories, LLC
- Merck & Co., Inc.
- Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
- Astellas Pharma Inc.
- AbbVie Inc.
- Cadila Healthcare Ltd.
- Sanofi
- Sun Pharmaceutical Industries Ltd.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
2 Research Methodology
3 Executive Summary
4 Idiopathic Intracranial Hypertension Overview
4.1 Guidelines and Stages
4.2 Pathophysiology
4.3 Screening and Diagnosis
4.4 Treatment Pathway
5 Patient Profile
5.1 Patient Profile Overview
5.2 Patient Psychology and Emotional Impact Factors
5.3 Risk Assessment and Treatment Success Rate
6 Current Scenario Evaluation and Regulatory Framework
6.1 Emerging Therapies and Clinical Trials Synopsis
6.2 Patent Landscape
6.2.1 Patent Overview
6.2.1.1 Patent Status and Expiry
6.2.1.2 Timelines from Drug Development to Commercial Launch
6.2.1.3 New Drug Application
6.2.1.3.1 Documentation and Approval Process
6.3 Cost of Treatment
6.4 Regulatory Framework
6.4.1 Regulatory Overview
6.4.1.1 US FDA
6.4.1.2 EU EMA
6.4.1.3 INDIA CDSCO
6.4.1.4 JAPAN PMDA
6.4.1.5 Others
7 Challenges and Unmet Needs
7.1 Treatment Pathway Challenges
7.2 Compliance and Drop-Out Analysis
7.3 Awareness and Prevention Gaps
8 Global Idiopathic Intracranial Hypertension Treatment Market
8.1 Global Idiopathic Intracranial Hypertension Treatment Market Overview
8.2 Global Idiopathic Intracranial Hypertension Treatment Market Analysis
8.2.1 Market Overview
8.2.1.1 Global Idiopathic Intracranial Hypertension Treatment Market Historical Value (2016-2022)
8.2.1.2 Global Idiopathic Intracranial Hypertension Treatment Market Forecast Value (2023-2031)
8.2.2 Global Idiopathic Intracranial Hypertension Treatment Market by Diagnosis Method
8.2.2.1 Market Overview
8.2.2.1.1 Carbonic Anhydrase Inhibitors
8.2.2.1.1.1 Acetazolamide
8.2.2.1.1.2 Methazolamide
8.2.2.1.1.3 Others
8.2.2.1.2 Loop Diuretics
8.2.2.1.2.1 Furosemide
8.2.2.1.2.2 Others
8.2.2.1.3 Corticosteroids
8.2.2.1.4 Anticonvulsant
8.2.2.1.4.1 Topiramate
8.2.2.1.5 Others
8.2.3 Global Idiopathic Intracranial Hypertension Treatment Market by Treatment Channel
8.2.3.1 Market Overview
8.2.3.1.1 Public
8.2.3.1.2 Private
8.2.4 Global Idiopathic Intracranial Hypertension Treatment Market by Region
8.2.4.1 Market Overview
8.2.4.1.1 North America
8.2.4.1.2 Europe
8.2.4.1.3 Asia Pacific
8.2.4.1.4 Latin America
8.2.4.1.5 Middle East and Africa
9 North America Idiopathic Intracranial Hypertension Treatment Market
9.1 Market Share by Country
9.2 United States of America
9.2.1 Historical Trend (2016-2022)
9.2.2 Forecast Trend (2023-2031)
9.3 Canada
9.3.1 Historical Trend (2016-2022)
9.3.2 Forecast Trend (2023-2031)
10 Europe Idiopathic Intracranial Hypertension Treatment Market
10.1 Market Share by Country
10.2 United Kingdom
10.2.1 Historical Trend (2016-2022)
10.2.2 Forecast Trend (2023-2031)
10.3 Germany
10.3.1 Historical Trend (2016-2022)
10.3.2 Forecast Trend (2023-2031)
10.4 France
10.4.1 Historical Trend (2016-2022)
10.4.2 Forecast Trend (2023-2031)
10.5 Italy
10.5.1 Historical Trend (2016-2022)
10.5.2 Forecast Trend (2023-2031)
10.6 Others
11 Asia Pacific Idiopathic Intracranial Hypertension Treatment Market
11.1 Market Share by Country
11.2 China
11.2.1 Historical Trend (2016-2022)
11.2.2 Forecast Trend (2023-2031)
11.3 Japan
11.3.1 Historical Trend (2016-2022)
11.3.2 Forecast Trend (2023-2031)
11.4 India
11.4.1 Historical Trend (2016-2022)
11.4.2 Forecast Trend (2023-2031)
11.5 ASEAN
11.5.1 Historical Trend (2016-2022)
11.5.2 Forecast Trend (2023-2031)
11.6 Australia
11.6.1 Historical Trend (2016-2022)
11.6.2 Forecast Trend (2023-2031)
11.7 Others
12 Latin America Idiopathic Intracranial Hypertension Treatment Market
12.1 Market Share by Country
12.2 Brazil
12.2.1 Historical Trend (2016-2022)
12.2.2 Forecast Trend (2023-2031)
12.3 Argentina
12.3.1 Historical Trend (2016-2022)
12.3.2 Forecast Trend (2023-2031)
12.4 Mexico
12.4.1 Historical Trend (2016-2022)
12.4.2 Forecast Trend (2023-2031)
12.5 Others
13 Middle East and Africa Idiopathic Intracranial Hypertension Treatment Market
13.1 Market Share by Country
13.2 Saudi Arabia
13.2.1 Historical Trend (2016-2022)
13.2.2 Forecast Trend (2023-2031)
13.3 United Arab Emirates
13.3.1 Historical Trend (2016-2022)
13.3.2 Forecast Trend (2023-2031)
13.4 Nigeria
13.4.1 Historical Trend (2016-2022)
13.4.2 Forecast Trend (2023-2031)
13.5 South Africa
13.5.1 Historical Trend (2016-2022)
13.5.2 Forecast Trend (2023-2031)
13.6 Others
14 Global Idiopathic Intracranial Hypertension Treatment Market Dynamics
14.1 Market Drivers and Constraints
14.2 SWOT Analysis
14.3 Porter's Five Forces Model
14.4 Key Demand Indicators
14.5 Key Price Indicators
14.6 Industry Events, Initiatives, and Trends
14.7 Value Chain Analysis
15 Supplier Landscape
15.1 Teva Pharmaceutical Industries Ltd
15.1.1 Company Overview
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisitions
15.1.5 Certifications
15.2 Mylan N.V.
15.2.1 Company Overview
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Pfizer, Inc.
15.3.1 Company Overview
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Upsher-Smith Laboratories, LLC
15.4.1 Company Overview
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Merck & Co., Inc.
15.5.1 Company Overview
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
15.6.1 Company Overview
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Astellas Pharma Inc.
15.7.1 Company Overview
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 AbbVie Inc.
15.8.1 Company Overview
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 Cadila Healthcare Ltd.
15.9.1 Company Overview
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 Sanofi
15.10.1 Company Overview
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
15.11 Sun Pharmaceutical Industries Ltd.
15.11.1 Company Overview
15.11.2 Product Portfolio
15.11.3 Demographic Reach and Achievements
15.11.4 Mergers and Acquisitions
15.11.5 Certifications
16 Global Idiopathic Intracranial Hypertension Treatment Market- Drug Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security